Shenglin Ma

4.0k total citations · 1 hit paper
67 papers, 1.3k citations indexed

About

Shenglin Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Shenglin Ma has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Shenglin Ma's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (18 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Shenglin Ma is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (18 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Shenglin Ma collaborates with scholars based in China, United States and United Kingdom. Shenglin Ma's co-authors include Qinghua Deng, Yaping Xu, Xinmin Yu, Shirong Zhang, Dan Su, Stephanie M. Smith, Herbert Yu, Haimin Yao, Wei Zhou and Jinhui Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shenglin Ma

63 papers receiving 1.3k citations

Hit Papers

Finger-inspired rigid-soft hybrid tactile sensor with sup... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Finger-inspired rigid-soft hybrid tactile sensor with superior sensitivity at high frequency
    2022 170 citations Jinhui Zhang, Haimin Yao et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenglin Ma China 20 561 538 439 282 223 67 1.3k
Priya Kumthekar United States 24 831 1.5× 854 1.6× 414 0.9× 122 0.4× 261 1.2× 146 2.1k
John Choi United States 18 176 0.3× 468 0.9× 575 1.3× 220 0.8× 192 0.9× 42 1.5k
Henry Cheung Netherlands 11 173 0.3× 411 0.8× 394 0.9× 106 0.4× 210 0.9× 20 812
Suzana Mária Fleury Malheiros Brazil 18 141 0.3× 157 0.3× 286 0.7× 187 0.7× 164 0.7× 61 1.2k
Kyu Sang Lee South Korea 21 213 0.4× 527 1.0× 289 0.7× 143 0.5× 157 0.7× 80 1.3k
Jun Konishi Japan 19 720 1.3× 866 1.6× 478 1.1× 79 0.3× 186 0.8× 48 2.1k
Michael Mitas United States 21 243 0.4× 628 1.2× 1.3k 2.9× 180 0.6× 371 1.7× 32 2.0k
Nancy Lane United States 12 335 0.6× 1.3k 2.4× 361 0.8× 662 2.3× 807 3.6× 13 1.9k
Douglas Houghton Campbell Australia 18 117 0.2× 273 0.5× 503 1.1× 173 0.6× 157 0.7× 48 1.0k
Dan Zhou China 13 216 0.4× 426 0.8× 387 0.9× 225 0.8× 334 1.5× 52 1.3k

Countries citing papers authored by Shenglin Ma

Since Specialization
Citations

This map shows the geographic impact of Shenglin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglin Ma more than expected).

Fields of papers citing papers by Shenglin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglin Ma. The network helps show where Shenglin Ma may publish in the future.

Co-authorship network of co-authors of Shenglin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglin Ma. A scholar is included among the top collaborators of Shenglin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglin Ma. Shenglin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Jie, et al.. (2025). Cellular polarity pilots breast cancer progression and immunosuppression. Oncogene. 44(12). 783–793.
2.
Wang, Yang, Yang Wang, Xinmeng Li, et al.. (2025). A Multifunctional Janus Electrospinning Dressing with Sequential Drug‐releasing Property for Programmed Treatments of Chronic Infected Wounds. Advanced Healthcare Materials. 14(27). e00188–e00188.
3.
Zeng, Hongjun, Mohammad Zoynul Abedin, Brian M. Lucey, & Shenglin Ma. (2024). Tail risk contagion and multiscale spillovers in the green finance index and large US technology stocks. International Review of Financial Analysis. 97. 103865–103865. 31 indexed citations
4.
Cai, Xinhao, Shenglin Ma, Imran Ullah Khan, et al.. (2024). Synergistic effect induces self crystallization of CsPbBr3 quantum dots in borosilicate glass matrix by LiF. Ceramics International. 50(23). 51278–51283. 3 indexed citations
5.
6.
Chen, Tiantian, Yu Duan, Shenglin Ma, et al.. (2024). Carbon monoxide-releasing nanomotors based on endogenous biochemical reactions for tumor therapy. Journal of Colloid and Interface Science. 663. 396–404. 7 indexed citations
7.
Han, Xinyan, Lian Chen, Shiqun Shao, et al.. (2024). Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy. iScience. 27(9). 110750–110750. 19 indexed citations
8.
He, Xintong, et al.. (2023). Cytoplasmic DNAs: Sources, sensing, and roles in the development of lung inflammatory diseases and cancer. Frontiers in Immunology. 14. 1117760–1117760. 7 indexed citations
9.
Zhang, Hongfang, Ke Zhang, Jing Yue, et al.. (2023). Cancer-associated fibroblasts facilitate DNA damage repair by promoting the glycolysis in non-small cell lung cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166670–166670. 15 indexed citations
10.
Zhang, Jinhui, Haimin Yao, Jiaying Mo, et al.. (2022). Finger-inspired rigid-soft hybrid tactile sensor with superior sensitivity at high frequency. Nature Communications. 13(1). 5076–5076. 170 indexed citations breakdown →
11.
12.
13.
Li, Weilong, Shenglin Ma, & Shirong Zhang. (2021). [Research Progress in CircRNA and Radiotherapy Resistance of Non-small Cell Lung Cancer].. SHILAP Revista de lepidopterología. 24(11). 770–776. 1 indexed citations
14.
Wang, Yuqing, Jie Huang, Qiong Wu, et al.. (2021). Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha. Frontiers in Oncology. 11. 668798–668798. 7 indexed citations
15.
Ma, Shenglin, Wenzhe Wang, Bing Xia, et al.. (2016). Multiplexed Serum Biomarkers for the Detection of Lung Cancer. EBioMedicine. 11. 210–218. 25 indexed citations
16.
Zhang, Shirong, et al.. (2015). Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation. Oncotarget. 6(8). 5832–5845. 34 indexed citations
17.
Liang, Xiaodong, Zhaoyun Li, Meifu Gan, et al.. (2014). Expression and Function Analysis of Mitotic Checkpoint Genes Identifies TTK as a Potential Therapeutic Target for Human Hepatocellular Carcinoma. PLoS ONE. 9(6). e97739–e97739. 39 indexed citations
18.
Wu, Yi‐Long, Yan Sun, Caicun Zhou, et al.. (2013). Survival without common toxicity criteria grade 3/4 toxicity following second-line treatment with pemetrexed for nonsquamous non-small cell lung cancer in Chinese patients. Chinese Medical Journal. 126(24). 4624–4628. 4 indexed citations
19.
20.
Zhong, Haijun, Yunshan Yang, Shenglin Ma, Weimin Mao, & Yiping Zhang. (2010). Enhanced antitumor effects of exosomes derived from heat-shocked E.G7-OVA tumor cells. Zhonghua weishengwuxue he mianyixue zazhi. 30(2). 164–168. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priya Kumthekar Breakdown of academic impact, for papers by John Choi Breakdown of academic impact, for papers by Henry Cheung Breakdown of academic impact, for papers by Suzana Mária Fleury Malheiros Breakdown of academic impact, for papers by Kyu Sang Lee Breakdown of academic impact, for papers by Jun Konishi Breakdown of academic impact, for papers by Michael Mitas Breakdown of academic impact, for papers by Nancy Lane Breakdown of academic impact, for papers by Douglas Houghton Campbell Breakdown of academic impact, for papers by Dan Zhou
Rankless by CCL
2026